Many Alzheimer ’s Experts Say Use of Aduhelm Should Be Sharply Limited

Even those who supported the F.D.A. ’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.

Source: NYT Health - June 22, 2021 Category: Consumer Health News Authors: Pam Belluck Tags: your-feed-science Alzheimer ' s Disease Aduhelm (Drug) Drugs (Pharmaceuticals) Labeling and Labels (Product) Clinical Trials s Assn Biogen Inc Food and Drug Administration your-feed-healthcare Source Type: news